Neurovascular Embolization Devices Market Expansion Continues, with Forecast Valuation of $1.8 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Neurovascular Embolization Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for neurovascular embolization devices has seen robust growth in the recent past. The market, which stood at $1.32 billion in 2024, is predicted to reach $1.4 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.2%. This growth during the historical period is the result of factors such as the escalating incidence of neurovascular disorders, an increasing number of older adults, the preference for minimally invasive medical procedures, enhancements in healthcare infrastructure, and a rise in healthcare spending.

Neurovascular Embolization Devices Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the neurovascular embolization devices market is projected to witness robust growth, expanding to $1.8 billion in 2029 with a compound annual growth rate (CAGR) of 6.5%. This predicted growth during the forecast period is fundamentally driven by the broadening applications in budding markets, the focus on patient-centered care, heightened awareness about neurovascular conditions, progress in imaging technologies, and increased funding in research and development. Key trends anticipated for the forecast span involve personalized treatment methods, the incorporation of artificial intelligence into treatment strategies, the introduction of advanced embolic materials, a transition to outpatient and ambulatory procedures, and the emergence of novel embolization techniques.

View the full report here:
https://www.thebusinessresearchcompany.com/report/neurovascular-embolization-devices-global-market-report

What Are the Drivers Transforming the Neurovascular Embolization Devices Market?
The neurovascular embolization devices market is forecasted to grow due to the increasing incidence of hemorrhages. Hemorrhages, characterized by uncontrolled internal or external bleeding, are becoming more common due to factors such as the aging population, higher hypertension rates, and the rising use of anticoagulant drugs. Neurovascular embolization devices come into play in managing hemorrhagic strokes by blocking abnormal blood vessels, thereby mitigating bleeding and protecting the brain from further damage. For example, research from King's College London in February 2024 predicts a surge by 59.4% in the number of intracerebral hemorrhage (a specific type of hemorrhage) cases and deaths among those aged 70 to 95 in the UK by 2050. Therefore, the increasing occurrence of hemorrhages is fuelling the expansion of the neurovascular embolization devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15871&type=smp

What Long-Term Trends Will Define the Future of the Neurovascular Embolization Devices Market?
Leading corporations dealing in neurovascular embolization devices are aiming to take advantage of advanced technological features like shield technology to treat brain aneurysms. This technology upgrades the embolization devices' performance and safety, improving their durability and life span. For example, in June 2022, Medtronic PLC, a healthcare technology institution based in Ireland, unveiled the Pipeline Vantage with Shield Technology in India. This fourth-generation flow diverter comes with an improved design for simplified utilization and increased reliability during endovascular procedures. The device encourages cellular growth on the interior lining of the blood vessel, thus providing a supportive structure that facilitates minimally invasive treatment for aneurysms, decreases rupture risks, and enhances patient outcomes.

Which Segments in the Neurovascular Embolization Devices Market Offer the Most Profit Potential?
The neurovascular embolization devices market covered in this report is segmented -

1) By Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products
2) By Treatment: Ischemic Stroke Solution, Hemorrhagic Stroke Solutions
3) By Indication: Brain Aneurysms, Arteriovenous Malformation, Other Indications
4) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:
1) By Embolization Coils: Detachable Coils, Bare Platinum Coils, Coils With Hydrogel Coatings
2) By Liquid Embolic Systems: Gluteraldehyde-Based Liquid Embolization, Onyx Liquid Embolic System
3) By Flow Diversion Stents: Stents With Dual-Layer Technology, Flow Diverters For Aneurysm Treatment
4) By Aneurysm Clips: Titanium Clips, Stainless Steel Clips
5) By Other Products: Balloons For Embolization, Microcatheters

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15871&type=smp

Which Firms Dominate the Neurovascular Embolization Devices Market by Market Share and Revenue in 2025?
Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Heraeus Holding, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc., Penumbra Inc., Asahi Intecc Co Ltd., MicroVention Inc., Balt USA LLC, Imperative Care Inc., InNeuroCo Inc., Acandis GmbH & Co KG, Rapid Medical Ltd., Emboline Inc., InspireMD Inc., QXMedical LLC, Vesalio LLC, EmbolX Inc

Which Regions Offer the Highest Growth Potential in the Neurovascular Embolization Devices Market?
North America was the largest region in the neurovascular embolization devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15871

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.